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DEFINITION
Chronic heart failure (CHF) is an abnormality of 
cardiac structure or function leading to failure of the 
heart to deliver oxygen at a rate commensurate with 
the requirements of the metabolizing tissues, despite
normal filling pressures (or only at the expense of
increased filling pressures)
http://eurheartj.oxfordjournals.org/content/ehj/33/14/1787.full.pdf
EPIDEMIOLOGY
• Approximately 1–2% of the adult population in developed countries 
has HF, with the prevalence rising to ≥10% among persons 70 years of 
age or older
• Heart failure accounts for 34% of cardiovascular-related deaths
• Approximately 670,000 new cases of  heart failure are diagnosed each 
year
• About 277,000 deaths are caused by heart failure each year
• Heart failure is the most frequent cause of hospitalization in patients 
older than 65 years, with an annual incidence of 10 per 1,000
• Rehospitalization rates during the 6 months following discharge are as 
much as 50%
http://eurheartj.oxfordjournals.org/content/ehj/33/14/1787.full.pdf
http://emedicine.medscape.com/article/163062-overview#a5
MITRAL VALVE DISEASE AND 
HEART FAILURE 1 
• Mitral valve disease and heart failure often occur 
together. In some cases, mitral valve disease leads to 
heart failure symptoms, while in other cases, heart 
failure results in mitral valve dysfunction.
• The author of a 2008 review article in the journal 
"Circulation" notes that mitral regurgitation, or 
insufficiency, associated with heart failure is linked to 
a worse prognosis than heart failure alone.
http://livehealthy.chron.com/mitral-valve-disease-heart-failure-6254.html
MITRAL VALVE DISEASE AND 
HEART FAILURE 1 
• Because mitral valve disease symptoms and heart failure 
symptoms often overlap, it can be tough to determine which 
came first
• Even so, mitral valve disease that is diagnosed early can 
generally be managed to prevent symptoms from progressing 
• The American College of Cardiology recommends that people 
who develop heart failure symptoms from mitral stenosis 
undergo surgery or a procedure called valvuloplasty to open up 
the narrowed valve
• In cases of severe mitral insufficiency, surgical repair of the 
mitral valve is recommended before heart failure develops
• People with severe mitral insufficiency who already have heart 
failure may also benefit from surgery, but the risk of 
complications is higher
http://livehealthy.chron.com/mitral-valve-disease-heart-failure-6254.html
OUR PATIENT
Patient I.L.V.
• 70 years old
• pensioner, worked as a salesman
• city resident
• Date of admission: 10 – October – 2015
COMPLAINTS
•Fatigue
• Dyspnea (paroxysmal nocturnal dyspnea (PND))
•Tachycardia
•Palpitation
•Nocturia
•Dizziness
ANAMNESIS MORBI 1.1
•These symptoms bother the patient more than 10 years
•In 2012 complaints (symptoms) were worsened, because of 
this, the patient admitted to Institution of general and urgent 
surgery V.T. Zaycev NAMS of Ukraine. After lab-tests and 
instrumental examination the diagnosis was: Combined mitral 
valve disease with predominance of insufficiency.
ANAMNESIS MORBI 1.2
Results of echocardiography before surgery(04.10.2012):                        
Conclusion: Combined mitral valve disease with 
predominance of insufficiency (MV Hg 3+), S of MV= 2,8
cm2. Dilatation of left atrium (4,3х5,2mm) and left ventricle. 
Pulmonary hypertension (Hg 40mm). EF=77% 
09.10.2012 the patient underwent mitral valve replacement 
with mechanical prosthesis St. Jude Medical No. 27. The 
patient has taken all drugs that were prescripted after the 
surgery. 
•This hospitalization is after increasing in data complaints
ANAMNESIS VITAE
•There was rheumatic fever attack in childhood. She had felt 
pain in the joins of lower extremities and got a temperature 
after sore throat. She don`t remember which treatment had 
got. Heart murmur had detected in the survey in adulthood. 
•Other infections, injuries, tuberculosis, sexually transmitted 
diseases were denied
•Hereditary diseases are not identified
•Allergological history is not burdened
OBJECTIVE STATUS 1 
•- General condition-moderate grave, Conciseness - clear, posture -
active, body position - sitting on the chair
•- Patient can orientate herself in place, time, her personality
•- Height – 158 sm, weight – 63 kg, BMI – 25,2
•- Skin and mucosae are pale pink, with redness on the nose 
•- Thyroid: no pathological changes
•- Skeleto – muscular system - deformity of the chest after sternotomy
•- BR – 22-24 /min
•- Lung percussion: intermediate below scapula angles from both sides
•- Lung auscultation: decreased vesicular breathing, wheezes inferial
parts both sides
•- Borders of the heart: left border – outside of midclavicular left line on 
2 cm
OBJECTIVE STATUS  2
•- Heart auscultation: rhythmic, heart tones – muffled, tone of 
mechanical valve, accentuated S2 over pulmonary artery
•- Pulse – rhythmic, 64 bts/min
•- BP 100 / 70 mm Hg
•- Abdomen: normal size, symmetric
•- Liver: liver margin is 1,5 cm below right rib cage
•- Spleen: normal
•- Pasternatsky symptom – negative from both sides
•- Edemas: absent
•- Varicose vein disease of lower extremities – absent
•- Stool: normal, everyday, dark color
PRELIMINARY DIAGNOSIS OF 
ADMISSION WARD PHYSICIAN
Mitral valve replacement with mechanical prosthesis 
(09/10/2012) about combined mitral valve disease 
with predominance of insufficiency. 
Heart failure Stage C, Class III by NYHA
PLAN OF SURVEY IN THE 
HOSPITAL
•Clinical blood test (CBT) and urine analysis
•Kidneys and liver function tests
•Electrolytes
•Lipid profile
•INR - international normalized ratio
•Rheumatic factor, antistreptolysin O 
•Electrocardiography(ECG)
•Chest X-ray
•Echocardiography with doppler
RISK FACTORS
•Coronary Artery Disease
•Age
•Obesity
•Tnt-chronic Kidney Disease
•Cigarette Smoking
•Diabetes Mellitus
•High Cholesterol
•African Descent
http://www.powershow.com/view/1eff6-YmM3N/Congestive_Heart_Failure_powerpoint_ppt_presentation
CLINICAL BLOOD TEST 
10/10/2015
Conclusion: Normal BC
index results
hemoglobin 140 120-150 g/l
erythrocytes 4.72 3.9-4.7 *10^12
Color index 0.94 0.85-1.15
hematocrit 42 % 36-42%
thrombocytes 250 160-320 g/l
leukocsytes 8.4 4.0-9.0 g/l
band 3 1-6 %
segmented 70 47-72 %
eosinophils 3 0.5-5 %
basophils 0 0-1.0 %
lymphocytes 19 19-37 %
monocytes 5 3-11 %
ESR 9 2- 15 mm/h
URINE ANALYSIS 10/10/15
Index Result Normal range 
Amount 140
color Yellow Light yellow
transparency Transparent Transparent 
Ontos.plotnost 1.017 1.001-1.040
Reaction (pH) 7 5.0-7.0
Protein(g/l) Not found To 0.033 g/l
Glucose (mmol/l) Not found -
leukocytes 4 6-8
Transitional epithelium Not found
Bacteria Not found
Conclusion: Normal urine test
BIOCHEMISTRY TEST DATA from 
10/10/15
Tests Result Normal range 
Creatinine  (CKD-EPI GFR) 104  (47 ml/min/1,73m2) 53-97 mcmol/l
Urea 6.0 4.2-8.3 mcmol/l
K 4.7 3.5-5 mEq/L
Na 143 136-145 mEq/L
Ca 10.2 9-10.5 mg/dL
INR 2.225 2-3
Rheumatic factor 8.01 To 14 ME/ml
Antistreptolysin O 40 To 200 IU/ml
AST 21 5-40 U/l
ALT 16 5-40 U/l
Total bilirubin 10.2 3,4—17,1 mcmol/l
Conclusion: The increased creatinine and decreased glomerular filtration 
rate (CKD-EPI GFR) that complies with chronic kidney failure stage 3
LIPID PROFILE 12/10/2015
Total cholesterol 7,3 3,1-5,2 MMOL/L
LDL-cholesterol 4,33 < 3,9 MMOL/L
HDL-cholesterol 1,96 > 1,42 MMOL/L
Triglycerides 0,74 0,14-1,82 MMOL/L
Conclusion: Hypercholesterolemia IIa type
Conclusion:Regular sinus rhythm with heart rate 59/min. Deviation 
of electric axis to the left. Left ventricular hypertrophy.
ELECTROCARDIOGRAPHY
10/10/2015
CHEST X-RAY 12/10/15 #2480
In the lower parts of 
lungs can be seen 
decreasing due to 
infiltration. In the inferior 
regions can be seen focal 
areas of infiltration. The 
increase in blood supply to 
the lungs. Diaphragm's 
cupulas are flattened. Heart 
borders are increased both 
sides. 
Conclusion:
Hypoventilation of the 
lungs. Pulmonary 
congestion. Pulmonary 
hypertension.
Mechanical prosthesis of mitral valve.
S of MV= 4,0 cm2. Dilatation of left atrium (4,0х4,4mm) 
and left ventricle. 
Pulmonary hypertension (Hg 37mm). EF=76% 
Conclusion: Status after mitral valve replacement 
(prosthetic valve) (2012). The prosthesis is functioning 
correctly.
HEART ULTRASOUND 13/10/2015
SYNDROMES
-Prosthetic valve
-Congestive heart failure
-Hyperlipidemia (atherosclerosis)
-Chronic renal failure
TYPES OF PROSTHETIC HEART 
VALVES
• Biologic
Stented
• Porcine xenograft
• Pericardial xenograft
Stentless
• Porcine xenograft
• Pericardial xenograft
• Homograft (allograft)
• Autograft
Percutaneous
http://www.lipidcenter.com/pdf/Circulation-Valvular-2014.pdf
● Mechanical
❏ Bileaflet
❏ Single tilting disc
❏ Caged-ball
SCORE RISK OF 
STROKE/TIA/SYSTEMIC EMBOLISM 
1.1
https://yandex.ua/images/search?text=CHAD2VASK&img_url=http%3A%2F%2Fwww.365heart.com%2Fupload%2Fnewsimg%2F20130922140851259.jpg&pos=5&rpt=simage
SCORE RISK OF 
STROKE/TIA/SYSTEMIC EMBOLISM 
1.2
Our patient get – 3 points
Stroke risk was 4.8% per year in >90,000 patients (the Swedish Atrial 
Fibrillation Cohort Study) and 6.7% risk of stroke/TIA/systemic 
embolism.
Score 2 or greater is "moderate-high" risk and should otherwise be an 
anticoagulation candidate. Oral anticoagulant, with well controlled 
Vitamin K Antagonist (VKA, e.g. warfarin with time in therapeutic range 
>70%), or a Non-VKA Oral Anticoagulant (NOAC, e.g. dabigatran, 
rivaroxaban, edoxaban or apixaban)
https://yandex.ua/images/search?text=CHAD2VASK&img_url=http%3A%2F%2Fwww.365heart.com%2Fupload%2Fnewsimg%2F20130922140851259.jpg&pos=5&rpt=simage
http://www.escardio.org/Guidelines-&-Education/Clinical-Practice-Guidelines/Valvular-Heart-Disease-Management-of
HAS-BLED RISK SCORE
ANTICOAGULATION THERAPY 
FOR PROSTHETIC VALVES 1.1
Class I
1. Anticoagulation with a VKA and international normalized ratio 
(INR) monitoring is recommended in patients with a mechanical 
prosthetic valve. (Level of Evidence: A)
2. Anticoagulation with a VKA to achieve an INR of 2.5 is 
recommended in patients with a mechanical AVR (bileaflet or current-
generation single tilting disc) and no risk factors for 
thromboembolism. (Level of Evidence: B)
3. Anticoagulation with a VKA is indicated to achieve an INR of 3.0 in 
patients with a mechanical AVR and additional risk factors for 
thromboembolic events (AF, previous thromboembolism, LV 
dysfunction, or hypercoagulable conditions) or an older-generation 
mechanical AVR (such as ball-in-cage). (Level of Evidence: B)
http://www.lipidcenter.com/pdf/Circulation-Valvular-2014.pdf
ANTICOAGULATION THERAPY 
FOR PROSTHETIC VALVES 1.2
4. Anticoagulation with a VKA is indicated to achieve an INR of 3.0 in 
patients with a mechanical MVR. (Level of Evidence: B)
5. Aspirin 75 mg to 100 mg daily is recommended in addition to 
anticoagulation with a VKA in patients with a mechanical valve 
prosthesis. (Level of Evidence: A)
http://www.lipidcenter.com/pdf/Circulation-Valvular-2014.pdf
RESULTS OF INTERNATIONAL 
NORMALIZED RATIO (INR) FOR 
MECHANICAL PROSTHESES
http://www.escardio.org/Guidelines-&-Education/Clinical-Practice-Guidelines/Valvular-Heart-Disease-Management-of
APPROACH TO HF 
DIAGNOSTICS
Criteria 1 and 2 should be fulfilled in all cases
1. Symptoms of heart failure (at rest or during 
exercise)
2. Objective evidence of cardiac dysfunction
(at rest)
(in cases where the diagnosis is in doubt)
3. Response to treatment directed towards heart failure
http://eurheartj.oxfordjournals.org/content/ehj/22/17/1527.full.pdf
TYPES OF HEART FAILURE
• Systolic (or squeezing) heart failure
– Decreased pumping function of the heart,
• Diastolic (or relaxation) heart failure
– The heart does not fill with blood properly
http://www.news-medical.net/health/Heart-Failure-Classification.aspx
TYPES OF HEART FAILURE
https://yandex.ua/images/search?p=1&text=classification%20heart%20failure%20systolic%20and%20diastolic&img_url=http%3A%2F%2Fwww.biomerieux.com
.au%2Fsites%2Fsubsidiary_au%2Ffiles%2Fresourcres-heart-failure-v3.jpg&pos=35&rpt=simage&_=1452525274591
FUNCTIONAL CLASSIFICATION
Heart failure may also be categorized according 
to how the heart is functioning and how severe 
the symptoms are.
The New York Heart Association Functional 
Classification includes 4 classes of heart failure:
http://www.news-medical.net/health/Heart-Failure-Classification.aspx
FUNCTIONAL CLASSES OF 
HEART FAILURE
http://www.heartfailure.com/hcp/epidemiology/heart-failure-classification.jsp?usertrack.filter_applied=true&NovaId=2935377031731912790
STAGES OF HEART FAILURE
Hunt SA et al. J Am Coll Cardiol. 2005; 46: e1-e86.
• Marked symptoms at rest despite maximal 
medical therapy (eg, those who are recurrently 
hospitalized or cannot be safely discharged from 
the hospital without specialized interventions)
Refractory 
end-stage HFD
• Known structural heart disease
• Shortness of breath and fatigue
• Reduced exercise tolerance
Symptomatic HF
C
• Previous MI
• LV systolic dysfunction
• Asymptomatic valvular disease
Asymptomatic HF
B
• Hypertension
• CAD 
• Diabetes mellitus
• Family history of cardiomyopathy
High risk for developing heart 
failure (HF)A
Patient DescriptionStage
SYMPTOMS ACCORDING TO THE 
SIDE OF THE HEART FAILURE 1.1
Heart failure may be categorized according to which side of the heart is 
affected. Such categories include:
•Left-sided failure or forward failure that leads to congestion in the 
lungs
•Backward failure or right sided failure leading to excess fluid 
accumulation in the body
•Failure of both sides or biventricular failure
http://www.news-medical.net/health/Heart-Failure-Classification.aspx
SYMPTOMS ACCORDING TO THE 
SIDE OF THE HEART FAILURE 1.2
https://yandex.ua/images/search?text=right%20sided%20heart%20failure&img_url=https%3A%2F%2Fs-media-cache-
ak0.pinimg.com%2Foriginals%2F89%2Ffb%2Fec%2F89fbec59a3d156bb13231048064cf155.jpg&pos=13&rpt=simage
SYMPTOMS ACCORDING TO THE 
SIDE OF THE HEART FAILURE 1.3
https://yandex.ua/images/search?text=right%20sided%20heart%20failure&img_url=http%3A%2F%2Fmedia-cache-
ak0.pinimg.com%2F736x%2F6f%2Fba%2Ff6%2F6fbaf6b9389c54159f22b46fe832a774.jpg&pos=0&rpt=simage
TREATMENT OF HEART FAILURE
Nowadays the quality and length of life are the most important in 
treatment of the patients.
Treatments include lifestyle and pharmacological modalities, and 
occasionally various forms of device therapy and rarely cardiac 
transplantation.
Treatment focuses on improving the symptoms and preventing the 
progression of the disease. Reversible causes of the heart failure also 
need to be addressed (e.g.infection, alcohol ingestion, anemia, 
thyrotoxicosis, arrhythmia, hypertension). 
https://en.wikipedia.org/wiki/Heart_failure#Prevention
TREATMENT. 
LIFESTYLE MODIFICATIONS
Dietary sodium and fluid restrictions should be implemented in all patients 
with congestive heart failure. Limiting patients to 2 g/day of dietary sodium 
and 2 L/day of fluid will lessen congestion and decrease the need for 
diuretics.
• 2-g Sodium diet
• Monitoring weight daily
• 2-L Fluid restriction
• Monitoring blood pressure
• Medications
• Smoking cessation
• Light aerobic exercise
• Knowing whom to call
• Achieving ideal weight
• Follow-up visits http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/heart-failure/
TREATMENT OF HEART FAILURE
https://yandex.ua/images/search?text=heart%20failure%20treatment%20algorithm&img_url=http%3A%2F%2Fwww.cardiotronic.net%2Fsites%2Fdefault%2Ffiles%2Fimages
%2Fheart-failure-treatment-algorithm.jpg&pos=0&rpt=simage
PHARMACOLOGICAL TREATMENT 
OF HEART FAILURE
http://www.escardio.org/Guidelines-&-Education/Clinical-Practice-Guidelines/Acute-and-Chronic-Heart-Failure
TREATMENTS WITH LESS-CERTAIN 
BENEFITS IN PATIENTS WITH 
SYMPTOMATIC SYSTOLIC  HF
http://www.escardio.org/Guidelines-&-Education/Clinical-Practice-Guidelines/Acute-and-Chronic-Heart-Failure
TREATMENT OF HEART FAILURE
http://www.escardio.org/Guidelines-&-Education/Clinical-Practice-Guidelines/Acute-and-Chronic-Heart-Failure
TREATMENT OF HEART 
FAILURE:DIURETICS
http://www.escardio.org/Guidelines-&-Education/Clinical-Practice-Guidelines/Acute-and-Chronic-Heart-Failure
FREDRICKSON CLASSIFICATION 
OF THE HYPERLIPIDEMIA
https://yandex.ua/images/search?text=FREDRICKSON%20CLASSIFICATION%20OF%20THE%20HYPERLIPIDEMIA&img_url=http%3A%2F%2Fimg.sparknotes.com%2Ffigures%2FA%2Fa55909797263ab66570
916b7fdcb774a%2Ftable1.gif&pos=3&rpt=simage&_=1452525948691
TREATMENT OF 
ATHEROSCLEROSIS
If patient have high cholesterol that cannot be controlled by diet and 
exercise, medication may be necessary. The best medicine to lower 
cholesterol is a statin, also known as a HMG-CoA reductase inhibitor. 
Statins block an enzyme called HMG-CoA reductase, which controls the 
production of cholesterol in the liver. Examples include:
● Lovastatin (Mevacor)
● Simvastatin (Zocor)
● Pravastatin (Pravachol)
● Fluvastatin (Lescol)
http://www.drugs.com/health-guide/atherosclerosis.html
DEFINITION OF CHRONIC 
KIDNEY DISEASE
https://yandex.ua/images/search?text=DEFINITION%20OF%20CHRONIC%20KIDNEY%20DISEASE&img_url=http%3A%2F%2Fwww2.kidney.org%2Fprofessionals%2FKDOQI%2Fguidelines_ckd%2FGif_File%2
Fkck_t2.gif&pos=0&rpt=simage&_=1452525831004
STAGES OF CHRONIC KIDNEY 
DISEASE
https://yandex.ua/images/search?text=STAGES%20OF%20CHRONIC%20KIDNEY%20DISEASE&img_url=http%3A%2F%2Fguidelines.diabetes.ca%2FApp_Themes%2FCDACPG%2Fimages%2FCh29_Tbl4_Stage
s_of_CKD.jpg&pos=11&rpt=simage&_=1452525891610
COMPLETE DIAGNOSIS OF OUR 
PATIENT IS:
Main: Mechanical prosthesis of mitral valve bileaflet
type (09/10/2012) about combined mitral valve 
disease with predominance of insufficiency. 
Complications: Congestive heart failure with 
preserved left ventricular pump function
(ejection fraction = 76%), III C functional class by 
NYHA. Chronic kidney failure Stage 3.
Concomitant disease: Atherosclerosis. 
Hyperlipidemia IIa type. 
LIST OF MEDICATIONS    
PRESCRIBED FOR OUR PATIENT 
IN HOSPITAL:
• Warfarin 5 mg 1 time/day
•Spironolactone 25 mg 1 time/day
• Ramipril 2.5 mg 1 time/day
• Bisoprolol 2.5 mg 1 time/day
• Torasemide 10 mg 1 time/day
• Atorvastatin 40 mg 1 time/day
TREATMENT
HF after valve surgery should lead to a search for
prosthetic-related complications, deterioration of 
repair, LV dysfunction or progression of another valve 
disease. Non-valvular related causes such as CAD, 
hypertension or sustained arrhythmias should also be 
considered. The management of patients with HF 
should follow the relevant guidelines.
http://www.escardio.org/Guidelines-&-Education/Clinical-Practice-Guidelines/Valvular-Heart-Disease-Management-of
CONCLUSION
The patient has the progression of heart failure due to 
the formation of acquired heart disease. The prosthetic 
valve has contributed to the stabilization stage and 
class of heart failure, but due to late surgical treatment 
regression of current heart failure became impossible.
